Preimplantation genetic screening is alive and very well: Really?

Though preimplantation genetic screening (PGS) was proven ineffective and costly for patients in a previous iteration, it is still marketed aggressively.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Citation Page #: e36.
Journal: Fertility & Sterility
Author Publication: Gleicher N, Kushnir VA, Barad DH.
Publication Link: http://www.fertstert.org/article/S0015-0282(13)03069-0/abstract
Date: 2013